Statement of Need: Urology Practitioners must develop competence in implementation of the latest clinical practice guidelines and appropriate use of new and emerging surgical techniques to ensure the highest standards of patient care and safety.
Learning Objectives
After participation in this CME activity, participants will be able to:
- Make informed decisions regarding using regenerative therapies for sexual medicine conditions, considering the current evidence surrounding these therapies.
- Incorporate the most important take-home messages from the 2024 ICSM conference into practice.
- Analyze the evidence surrounding super physiologic testosterone therapy and its potential benefits and harms.
- Provide impactful care to patients with female sexual dysfunction.
- Utilize contemporary techniques for managing complex penile prosthesis scenarios.
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The American Urological Association designates this (live) activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Evidence-Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
Disclosures of Relevant Financial Relationships: Please visit www.auanet.org/AUA2025/speakers/disclosures for a detailed disclosure report.
AUA Disclosure Policy: Please visit www.auanet.org/AUA2025/attendee-info/cme-credits/cme-information to review the complete policy related to disclosure of relevant financial relationships with ineligible companies and mitigation of identified conflicts of interest.
Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
